دورية أكاديمية
Practice patterns in post-treatment surveillance in patients with primary epithelial ovarian cancer.
| العنوان: | Practice patterns in post-treatment surveillance in patients with primary epithelial ovarian cancer. |
|---|---|
| المؤلفون: | DeMari J; Department of Obstetrics and Gynecology, The Ohio State University Medical Center, Columbus, Ohio, USA joseph.demari@osumc.edu., Vetter MH; Department of Obstetrics and Gynecology, The Ohio State University Medical Center, Columbus, Ohio, USA., Chandra S; The Ohio State University College of Medicine, Columbus, Ohio, USA., Hays JL; Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio, USA., Salani R; Department of Obstetrics and Gynecology, The Ohio State University Medical Center, Columbus, Ohio, USA. |
| المصدر: | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2021 Jun; Vol. 31 (6), pp. 888-892. Date of Electronic Publication: 2020 Aug 05. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2019- : [London] : BMJ Original Publication: Cambridge, MA, USA : Blackwell Scientific Publications, c1991- |
| مواضيع طبية MeSH: | Chronic Disease Indicators*, Carcinoma, Ovarian Epithelial/*therapy, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Middle Aged ; Retrospective Studies ; Young Adult |
| مستخلص: | Background: The Society of Gynecologic Oncology created guidelines to standardize cost-effective clinical surveillance for detection of recurrence of gynecologic cancers. Objective: To determine practice patterns for surveillance of primary ovarian cancer after complete response to therapy and to identify the percentage of clinicians who follow the surveillance guidelines endorsed by the Society of Gynecologic Oncology. Methods: A single-institution retrospective cohort study was conducted including patients with epithelial ovarian cancer with a complete response to primary therapy between January 2012 and December 2016. Patients were excluded if they were participating in clinical trials that required routine imaging. Data on surveillance and recurrence were collected. Descriptive statistics as well as Fisher's exact test and chi-square test were performed due to the exploratory nature of the study. Results: A total of 184 patients met the inclusion criteria. Median follow-up for the cohort was 37 months (range 6-80). Surveillance was completed in compliance with Society of Gynecologic Oncology guidelines in 78% of patients. Of 39 visits that were non-compliant, 44% (17) were patient initiated (scheduling conflict, missed appointment), 15% (6) were due to the provider intentionally scheduling alternative follow-up, while 41% (16) were off schedule due to problem visits (patient complaint of symptoms). Patients with early-stage cancers were more likely than advanced-stage patients to be non-compliant (33% vs 15%, p=0.006). Patients with non-serous histologies had a higher frequency of non-compliance (31% vs 16%, p=0.035). When stratified by early versus advanced stage, there was no difference in progression-free survival or overall survival based on compliance. Conclusions: Overall, there was a relatively high rate of compliance with Society of Gynecologic Oncology surveillance guidelines for patients with epithelial ovarian cancer. Patients with non-serous histologies and patients with early-stage disease had a higher rate of non-compliance, and these patients may represent special groups that would benefit from additional survivorship education. Competing Interests: Competing interests: None declared. (© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.) |
| فهرسة مساهمة: | Keywords: neoplasm recurrence, local; ovarian cancer |
| تواريخ الأحداث: | Date Created: 20200808 Date Completed: 20220128 Latest Revision: 20220128 |
| رمز التحديث: | 20240829 |
| DOI: | 10.1136/ijgc-2020-001522 |
| PMID: | 32759182 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1525-1438 |
|---|---|
| DOI: | 10.1136/ijgc-2020-001522 |